HY

Hemchandra Yadunandan Panjikar

Active Director Director DIN 07230533
DIN 07230533 First appointment Jul 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Jul 2015
Shareholding value •••• Premium profile

About Hemchandra Yadunandan Panjikar

Data last updated:

Hemchandra Yadunandan Panjikar is a Director at Meril Endo Surgery Private Limited (since 2015) and Director at Meril Medical Innovations Private Limited (since 2022). The companies operate in Healthcare and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹376 Cr; the largest is Meril Endo Surgery Private Limited at ₹368 Cr (FY 2025). Earlier, Hemchandra Yadunandan Panjikar was an Additional Director at Meril Life Sciences Private Limited (2023).

DIN 07230533
Primary Designation Director
Industry Healthcare
First Appointment 07 Jul 2015
Oldest Company Age 15 yrs
Largest company Meril Endo Surgery Private Limited · ₹368 Cr (FY 2025)
Combined revenue ₹376 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meril Endo Surgery Private Limited U33110GJ2011PTC065366
Director07 Jul 20152011₹368 Cr (FY 2025)Active
Director04 Nov 20222022₹8.03 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meril Life Sciences Private Limited U24239GJ2007PTC051137
Additional Director11 Mar 20232007₹1,730 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Hemchandra Yadunandan Panjikar

NameDINCompanyDesignation
Alpesh Mansukhlal ChaniyaraMeril Endo Surgery Private LimitedCompany Secretary
Rajnikant Gandalal Vyas00837447Meril Endo Surgery Private LimitedWhole-Time Director
Ansh Bharat DesaiMeril Medical Innovations Private LimitedCompany Secretary
Hitendra Arjan Ghiyad09782659Meril Medical Innovations Private LimitedDirector

Directorship timeline

Open interactive timeline →
Meril Medical Innovations Private Limited
Meril Endo Surgery Private Limited
Meril Life Sciences Private Limited
Premium access

Shareholding and investment profile for Hemchandra Yadunandan Panjikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemchandra Yadunandan Panjikar

Hemchandra Yadunandan Panjikar currently holds 2 directorships: Meril Endo Surgery Private Limited (Director, since 07 Jul 2015, revenue ₹368 Cr (FY 2025)); Meril Medical Innovations Private Limited (Director, since 04 Nov 2022, revenue ₹8.03 Cr (FY 2025)).

Hemchandra Yadunandan Panjikar was first appointed on 07 Jul 2015 as Director at Meril Endo Surgery Private Limited. The most recent appointment on record is 11 Mar 2023 at Meril Life Sciences Private Limited.

The 2 current companies of Hemchandra Yadunandan Panjikar that report revenue have a combined latest revenue of ₹376 Cr: Meril Endo Surgery Private Limited ₹368 Cr (FY 2025); Meril Medical Innovations Private Limited ₹8.03 Cr (FY 2025).

Hemchandra Yadunandan Panjikar held 1 earlier board appointment: Meril Life Sciences Private Limited (Additional Director, 11 Mar 2023 to 08 Sep 2023).

The current boards of Hemchandra Yadunandan Panjikar's companies include Alpesh Mansukhlal Chaniyara (Meril Endo Surgery Private Limited), Rajnikant Gandalal Vyas (Meril Endo Surgery Private Limited), Ansh Bharat Desai (Meril Medical Innovations Private Limited), Hitendra Arjan Ghiyad (Meril Medical Innovations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available